Refine by
Heart Failure Articles & Analysis: This-Month
3 news found
The appointments enable Hemostemix to sell VesCell™ in Florida to podiatrist and vascular surgeons, to treat PAD & CLTI; and to cardiologist to treat Angina, Ischemic Cardiomyopathy, Dilated Cardiomyopathy and Congestive Heart Failure. The additions to the leadership team are top-tier talent with a proven track record of success in the ...
Hemostemix (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company“) is excited to highlight a groundbreaking research article published in Cells on June?29,?2025, by Dr. Fraser C. Henderson Sr. and Ms. Kelly?Tuchman, exploring how a combination of the patient’s own ACP-01 and NCP-01 (autologous blood-derived cell precursors) may support the long-term ...
Hemostemix (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company“) is excited to highlight a groundbreaking research article published in Cells on June?29,?2025, by Dr. Fraser C. Henderson Sr. and Ms. Kelly?Tuchman, exploring how a combination of the patient’s own ACP-01 and NCP-01 (autologous blood-derived cell precursors) may support the long-term ...